Peter Brossart Selected Research

Peter Brossart Research Topics

Disease

93	Neoplasms (Cancer) 04/2024 - 10/2002
16	Multiple Myeloma 12/2024 - 02/2003
13	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 03/2003
13	Squamous Cell Carcinoma of Head and Neck 01/2023 - 05/2016
10	Infections 01/2024 - 10/2002
10	Melanoma (Melanoma, Malignant) 06/2021 - 10/2008
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2020 - 01/2005
9	Carcinoma (Carcinomatosis) 04/2024 - 10/2008
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 01/2004
8	Leukemia 08/2016 - 07/2003
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 05/2016
5	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023 - 12/2010
5	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 08/2013
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2008 - 07/2003
4	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2011
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2019 - 10/2012
3	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2023 - 05/2015
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 08/2013
3	Inflammation (Inflammations) 08/2021 - 11/2003
3	Neutropenia 06/2020 - 04/2010
3	Acute Promyelocytic Leukemia 01/2020 - 02/2017
3	Lymphoma (Lymphomas) 01/2020 - 02/2004
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 04/2016
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 05/2016
3	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2007 - 06/2005
2	Virus Diseases (Viral Diseases) 01/2024 - 10/2005
2	COVID-19 11/2023 - 01/2021
2	Residual Neoplasm 01/2023 - 03/2008
2	Febrile Neutropenia 01/2022 - 05/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2021 - 01/2005
2	Cutaneous Lupus Erythematosus 08/2021 - 01/2017
2	Cholangiocarcinoma 01/2021 - 01/2019
2	Disease Progression 01/2019 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 03/2003

Drug/Important Bio-Agent (IBA)

19	AntigensIBA 01/2021 - 02/2003
18	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2003
14	RNA (Ribonucleic Acid)IBA 09/2020 - 02/2003
13	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2016
11	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2018
10	LigandsIBA 01/2020 - 01/2003
9	VaccinesIBA 01/2024 - 01/2008
9	Messenger RNA (mRNA)IBA 01/2023 - 06/2004
8	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020 - 11/2008
8	Peptides (Polypeptides)IBA 09/2008 - 10/2002
7	EpitopesIBA 01/2020 - 03/2003
6	CytokinesIBA 01/2017 - 10/2002
6	Tyrosine Kinase InhibitorsIBA 01/2016 - 06/2005
5	C-Reactive ProteinIBA 01/2024 - 01/2022
5	PlatinumIBA 08/2023 - 01/2018
5	Bortezomib (Velcade)FDA Link 10/2021 - 01/2006
5	IpilimumabIBA 06/2021 - 01/2013
5	ruxolitinibIBA 01/2021 - 08/2013
5	NivolumabIBA 01/2019 - 01/2018
5	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 01/2004
5	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 09/2013 - 06/2003
4	AlbuminsIBA 01/2024 - 01/2023
4	Janus Kinase InhibitorsIBA 01/2021 - 08/2013
4	InterferonsIBA 09/2020 - 06/2009
4	Neoplasm Antigens (Tumor Antigens)IBA 03/2008 - 03/2003
4	Proteasome InhibitorsIBA 03/2006 - 04/2005
3	atezolizumabIBA 01/2024 - 01/2023
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2004
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2020
3	Janus KinasesIBA 01/2021 - 08/2013
3	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 01/2016
3	Gemcitabine FDA Link 01/2021 - 10/2011
3	B7-H1 AntigenIBA 01/2020 - 04/2016
3	Interferon-alpha (Interferon Alfa)IBA 08/2016 - 06/2005
3	Cancer VaccinesIBA 10/2008 - 02/2004
2	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 06/2008
2	ChemokinesIBA 01/2024 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 05/2023 - 06/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2023 - 04/2013
2	Docetaxel (Taxotere)FDA Link 05/2023 - 01/2023
2	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2020
2	SeptinsIBA 01/2023 - 01/2020
2	HLA-DR Antigens (HLA-DR)IBA 01/2022 - 01/2017
2	SteroidsIBA 08/2021 - 01/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 01/2019
2	InterleukinsIBA 01/2021 - 06/2015
2	mRNA VaccinesIBA 01/2021 - 01/2010
2	Azacitidine (5 Azacytidine)FDA Link 09/2020 - 11/2013
2	Arsenic Trioxide (Trisenox)FDA Link 01/2020 - 02/2017
2	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 01/2020
2	Peptide Receptors (Peptide Receptor)IBA 05/2019 - 10/2018
2	Radioisotopes (Radionuclides)IBA 05/2019 - 10/2018
2	CurcuminIBA 01/2019 - 07/2016
2	Phosphotransferases (Kinase)IBA 01/2017 - 02/2012
2	GlucocorticoidsIBA 01/2017 - 08/2007
2	Small Interfering RNA (siRNA)IBA 01/2017 - 08/2015

Therapy/Procedure

50	Therapeutics 01/2024 - 07/2003
24	Immunotherapy 04/2024 - 01/2004
13	Drug Therapy (Chemotherapy) 03/2024 - 01/2009
9	Stem Cell Transplantation 01/2021 - 01/2012
3	Drug Tapering 01/2021 - 01/2019
3	Radiotherapy 01/2016 - 02/2004
2	Hematopoietic Stem Cell Transplantation 08/2023 - 10/2019
2	Palliative Care (Palliative Therapy) 02/2023 - 01/2020
2	Cell Transplantation 08/2021 - 05/2015
2	Transplantation 01/2019 - 01/2014